BMY Bristol-Myers Squibb Co.

63.97-1.66 (-2.53%)
Close: February 24, 2020

Quote

Previous Close
$63.97
Day Range
$63.69-$65.06
52 Week Range
$42.48-$68.34
Volume
12,101,022
Avg Volume
13,426,695
Dividend TTM
$1.68 (2.56%)
Ex-Dividend Date
2020-01-02

Valuation

Market Cap
$149.96B
Enterprise Value (EV)
$181.30B
PE Ratio
29.07
EV/EBITDA
NAN
Price/Sales
5.74
Price/Book
-
PEG Ratio
0.98

Financials

Revenue
$26.15B
Gross Profit
$18.27B
EBITDA
-
EPS, ttm
$2.20
Profit Margin
13.15%
Revenue/Employee
-
Next Earnings Date
4/23/2020 (58 days)
Debt to Equity
-
Debt
$46.73B
Cash
$15.39B
Net Debt
$31.34B

Performance

Beta
0.69
200 Day Moving Avg
$53.45
50 Day Moving Avg
$64.80
52 Week Change
29.58%
YTD Change
0.26%
1 Month Change
-2.67%
3 Month Change
15.44%
6 Month Change
37.39%
1 Year Change
30.92%
2 Year Change
-1.35%
5 Year Change
7.08%

Share Count

Shares Outstanding
2.3B
Float
2.3B
Restricted Shares
2.3M
Restricted Shares, %
0.10%

Bristol-Myers Squibb Co. Company Details

Sector: Health Technology

Industry: Pharmaceuticals: Major

CEO: Giovanni Caforio

Website: http://www.bms.com

Description: Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Employees: -